Osaka, Japan

Hajime Yoshizumi


Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 258(Granted Patents)


Location History:

  • Takatusuki, JA (1978)
  • Takatsuki, JP (1981 - 1988)
  • Mishima, JP (1988)
  • Osaka, JP (1985 - 1992)
  • Nara, JP (1999)

Company Filing History:


Years Active: 1978-1999

Loading Chart...
18 patents (USPTO):Explore Patents

Title: Hajime Yoshizumi: Innovator in Medical Solutions

Introduction

Hajime Yoshizumi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical innovations, holding a total of 18 patents. His work focuses on developing solutions for health-related issues, particularly in the area of hypertension and its associated medical symptoms.

Latest Patents

One of his latest patents is a method for preventing or alleviating cerebral apoplexy. This invention discloses a preventive or ameliorant of hypertension and medical symptoms caused by it. The active ingredient in this food or beverage is a dioxabicyclo-3.3.0!octane derivative, which is designed to help manage hypertension effectively. Another notable patent is a process for producing peroxidase, which was obtained from a fast-growing microorganism of the genus Coprinus cinereus. This fungal peroxidase serves as a clinical or diagnostic reagent and can be utilized as a marker enzyme in enzyme immunoassays.

Career Highlights

Throughout his career, Hajime Yoshizumi has worked with several notable companies, including Suntory Limited and Hideoki Ogawa. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Hajime has collaborated with several professionals in his field, including Teruo Amachi and Takaharu Tanaka. These collaborations have further enhanced his research and development efforts.

Conclusion

Hajime Yoshizumi is a distinguished inventor whose work in medical innovations has the potential to significantly impact health management. His patents reflect a commitment to addressing critical health issues, particularly hypertension.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…